Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
BMC Cancer|January 11, 2022
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohortVerena Schlintl, Florian Huemer, Gabriel Rinnerthaler, et al.
Clinical & Experimental Metastasis|August 25, 2014
αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancerAnna Sophie Berghoff, Astrid Kerstin Kovanda, Thomas Melchardt, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 13, 2021
Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancerKonstantin Schlick, Steiner Markus, Florian Huemer, et al.
Journal of Clinical Pathology|December 9, 2015
The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphomaKatharina T Troppan, Thomas Melchardt, Kerstin Wenzl, et al.
European Journal of Haematology|February 14, 2015
The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patientsKatharina T Troppan, Thomas Melchardt, Alexander Deutsch, et al.
BMC Cancer|November 8, 2018
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, et al.
Annals of Hematology|June 5, 2018
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II studyAlexander Egle, Michael Steurer, Thomas Melchardt, et al.
Neuropathology and Applied Neurobiology|September 27, 2014
Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 casesAnna S Berghoff, Aysegül Ilhan-Mutlu, Carina Dinhof, et al.
Annals of Hematology|June 24, 2018
Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II studyAlexander Egle, Michael Steurer, Thomas Melchardt, et al.
Journal of Cancer Research and Clinical Oncology|July 21, 2022
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocolFlorian Huemer, Stefan Hecht, Bernhard Scharinger, et al.
Pageof 9